DrugRadar

DrugRadar is a clean, fast tracker for newly approved pharmaceutical drugs and late-stage clinical trials, built on official public regulatory data. WHAT YOU CAN TRACK • Recent FDA drug approvals with Marketing Authorization dates • EMA (European) approvals and estimated EC decision dates • CDER novel new-drug approvals • Upcoming PDUFA action dates • Critical medicines and late-stage clinical trials (ClinicalTrials.gov) WHY DRUGRADAR • Sourced from official public data: openFDA, EMA, and ClinicalTrials.gov • No account, no ads, no tracking — your data stays on your device • Fast, focused, and easy to scan DrugRadar presents public regulatory information for general informational purposes only. It is not medical advice and is not a substitute for consultation with a qualified healthcare professional. DrugRadar is an independent project and is not affiliated with or endorsed by the FDA, EMA, or the U.S. National Library of Medicine.